EFRELand Brandenburgbe Berlin

Medical Technology News

18.10.2017

World Health Summit – Day Three: A Call to Action

The ninth World Health Summit concluded in Berlin with 2,000 participants from over 80 countries and a clear call to action. Over three days, more than 250 speakers discussed the most pressing challenges in Global Health and...► Read more ...

INTERVIEW: Dr. Rolf Zettl, Chief Financial Officer, BIH

Dr. Rolf Zettl joined the Berlin Institute of Health (BIH) in March 2016, having previously served as managing director of the Helmholtz Association of German Research Centres. In his new position as Chief Financial Officer, he...► Read more ...

12.10.2017

Adapter for inserting a dental implant

Reference Number TO 32-00048► Read more ...

12.10.2017

Method and arrangement for identification and correction of optical aberrations

Challenge: Optical microscopy is an indispensable tool for biomedical research. Yet, the same structures that make biological samples interesting to study under a microscope (such as cells, vasculature and subcellular organelles)...► Read more ...

11.10.2017

Charité and MDC sign cooperation agreement with Sanofi in Germany

The BIH, the Charité – Universitätsmedizin Berlin, the Max Delbrück Center for Molecular Medicine in the Helmholtz Association(MDC) and Sanofi, Germany GmbH signed a joint research framework agreement in Berlin on October 4,...► Read more ...

10.10.2017

BIH UND CHARITÉ APPOINT FIRST RESEARCHER TO ONE OF THE THREE NEW BIH JOHANNA QUANDT PROFESSORSHIPS

On October 1, 2017, Dr. Petra Ritter assumed the position of BIH Johanna Quandt Professor for Brain Simulation at Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin. This W2 professorship is funded by...► Read more ...

05.10.2017

DIGITAL HEALTH ACCELERATOR FROM BERLIN HEALTH INNOVATIONS STARTS WITH THREE TEAMS

Berlin Institute of Health (BIH) offers digital health innovators co-working space and expertise► Read more ...

20.09.2017

Investment GUB Wagniskapital GmbH & Co. KGaA: Increase of Holdings in Natural Dental Implants AG, Berlin

The Venture Capital Company GUB Wagniskapital, Obersulm, has increased its investment in Natural Dental Implants AG (NDI), a dental technology company based in Berlin by one million Euros, from 3.3 million Euros to a total of 4.3...► Read more ...

19.09.2017

BERLIN INSTITUTE OF HEALTH PARTNERS WITH STARTUPBOOTCAMP DIGITAL HEALTH

Berlin Institute of Health (BIH) announces a partnership with Startupbootcamp Digital Health to collaborate on its start-up accelerator program in Berlin starting in September 2017.► Read more ...

10.08.2017

MOLOGEN AG: Important milestones achieved in clinical trials during the first half 2017

Results from the TEACH (HIV) and IMPULSE (small cell lung cancer) clinical trials with lefitolimod, Completion of patient recruitment for the IMPALA pivotal study (colorectal cancer), Promising results obtained from pre-clinical...► Read more ...